Hecht Beth Insider Trades & Stock Holdings

Chief Legal Officer and Corporate Secretary · Xeris Biopharma Holdings, Inc. · Latest filing Oct 1, 2026

Hecht Beth, Chief Legal Officer and Corporate Secretary at Xeris Biopharma Holdings, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($156.79K), net -$156.79K. Latest filing: disposed of 16.67K shares of $XERS on Oct 1, 2026 at $9.41.

Trades on file

1

Open-market bought

$0

Open-market sold

$156.79K

Net open-market

-$156.79K

Latest filing

Oct 1, 2026

All insider trades by Hecht Beth

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$XERS	Sell (Open-market sale) 10b5-1	16.67K	$9.41	$156.79K						Chief Legal Officer and Corporate Secretary		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Hecht Beth traded

• $XERS

Frequently asked questions

Has Hecht Beth been buying or selling stock?

Hecht Beth has 0 open-market purchases and 1 open-market sale on file, net -$156.79K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Hecht Beth's latest insider trade?

disposed of 16.67K shares of $XERS on Oct 1, 2026 at $9.41.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.